Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

The Allelic Spectrum of SCN4A-Associated Disease in Over 7000 Individuals: Lessons Learned From Genetic Testing

ASHG 2024

American Society for Human Genetics

Denver, CO, Nov 5, 2024

Poster presentation: The Allelic Spectrum of SCN4A-Associated Disease in Over 7000 Individuals: Lessons Learned From Genetic Testing

Authors: Lopes C

Specialty: Genetics, Neurology

Related content

Conference Presentation
Recalibration of Scoring Metrics to Assess the Pathogenicity of Constitutional Copy Number Variants (CNVs)
Conference Presentation
A Streamlined Process for Assessing the Strength of a Relationship Between a Gene and Specific Disease
Conference Presentation
Whole exome sequencing genotype-first analysis: an efficient way of identifiying diagnostic and candidate gene variants
Conference Presentation
Genomic sequencing tests generate less uncertainty and higher diagnostic yield compared to multi-gene panel-based tests: results of over 1.5 million tests

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.